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Reported prevalence rates for anxiety disorder in later life vary
between 3.2 and 14.2%.1 Setting aside specific phobias, generalised
anxiety disorder is the most common in nearly all population
surveys (range of prevalence rates 1.2–7.3%), followed by social
phobia (range 0.6–2.3%), obsessive–compulsive disorder (range
0.1–0.8%), panic disorder (range 0.1–1.0%) and post-traumatic
stress disorder (PTSD) (range 0.4–1.0%).1 A Canadian study
showed that 12-month prevalence rates for late-life anxiety
disorder increased from 5.6% based on DSM-IV criteria to
26.2% when well-defined subthreshold disorders were also
included.2 Interestingly, older persons with full-blown anxiety
disorders and those with subthreshold anxiety disorders did not
differ in health and health behaviour characteristics, whereas
compared with respondents without anxiety both groups were
psychiatrically and somatically less healthy and used healthcare
services more frequently.2
More optimistic is the great progress in the treatment of
anxiety disorder over the past decades. Many well-designed
randomised controlled trials (RCTs) have proven the efficacy for
both cognitive–behavioural therapy (CBT) and serotonergic
antidepressants. Moreover, the availability of disorder- and
symptom-specific cognitive–behavioural techniques for anxiety
is still increasing. The wealth of RCTs has led to evidence-based
treatment algorithms summarised in guidelines for most, if not
all, individual anxiety disorders.
Undertreatment of late-life anxiety
Unfortunately, the vast majority of older people with anxiety
disorders are not receiving appropriate treatment. A Dutch
population-based study showed that less than 10% of people aged
55 years or older with anxiety disorders received psychological
treatment or antidepressant drug therapy.3 A more recent
population-based study in Canada showed that only 20.6% of
older persons with anxiety disorders had consulted any health
service for their anxiety problem in the past year.2 These low
treatment rates are problematic as the consequences of late-life
anxiety disorder are considerable. Late-life anxiety disorder is
associated with increased healthcare consumption, reduced
quality of life and high disability rates. When left untreated, it
has a tendency to become chronic and substantially increases
the risk for developing major depression. Furthermore, between
25 and 43% of older people with anxiety disorders use benzo-
diazepines chronically (e.g. Grenier et al2), the majority of whom
without ever having received a trial of serotonergic antidepressants
or CBT. Although guidelines leave room for the use of
benzodiazepines, these agents are never considered first choice.
Based on their risk–benefit ratio, their use becomes even less
favourable with increasing age, and is reserved for short-term
crisis management or a final step if CBT and serotonergic
antidepressants have failed.
Several factors contribute to the low treatment rates of late-life
anxiety disorder. Ageism may be an important explanation as it
hinders both adequate detection and, if recognised, adequate
treatment. Physicians, therapists, older patients as well as next
of kin, often interpret anxiety symptoms and avoidance behaviour
in later life as normal and more or less acceptable, when in reality
the patient may have a psychiatric disorder. Furthermore, as a
result of the ageing process itself, somatic morbidity increases
and may partially overlap with symptoms of panic and anxiety.
In addition, symptoms of arousal as well as anxiety cognitions
tend to decline with increasing age, resulting in some authors
characterising anxiety in later life as a less devastating condition
compared with anxiety disorder earlier in life. Nonetheless,
avoidance behaviour, an important negative consequence of
anxiety, does not seem to decline with age.
Available evidence
The need to properly treat late-life anxiety is increasingly
recognised, acknowledged by the emergence of several meta-
analyses4–7 and an even greater number of review articles. In
summary, these articles conclude that late-life anxiety disorder
can be efficiently treated with both serotonergic antidepressants
and CBT. These conclusions, however, are rather tentative as the
same reviews and meta-analyses point to the lack of well-designed
RCTs in older age groups. This scarcity has even led to the
combining of randomised and non-randomised studies within
some meta-analyses.4,6 A closer look at the RCTs included in these
meta-analyses (or published thereafter) reveals three other
important limitations.
First, many studies focus on anxiety symptoms instead of
anxiety disorders. The challenge of clinical practice, however, is
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Although anxiety disorders are common in later life, only a
minority of patients receive appropriate treatment. The
scarcity of clinical trials and decreasing effectiveness of
current treatment modalities with advancing age, as shown
by Wetherell and colleagues in this issue, argue for more
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to detect and treat those patients who need treatment. Patients
who are likely to have a favourable course (i.e. those without a
psychiatric disorder) should not be overtreated. All RCTs
restricted to patients with anxiety disorders were confined to
generalised anxiety disorder or included a heterogeneous sample
of patients with generalised anxiety disorder, panic disorder or
social phobia. To date, only one RCT has been conducted in panic
disorder specifically,8 whereas no clinical trials are available that
evaluate treatment of social phobia, hypochondria, obsessive–
compulsive disorder or PTSD in later life.
Second, most studies are relatively small. The 16 RCTs
evaluating any form of psychotherapy4–7 included on average 16
patients (range 5–30) in the active treatment condition. Recently,
70 older patients with generalised anxiety disorder received CBT
within a larger RCT.9 Although pharmacotherapy trials (n= 15)
in this field have included more patients, these trials remain small,
with an average number of 43 patients in the active treatment
condition.4
Third, one may argue about the definition of ‘later life’, as the
average age of patients in the available studies is just below 70
years.4 The relatively low average age is due to the fact that many
studies include patients from the age of 55 years and over. This age
cut-off contrasts with clinical practice where old age psychiatry
departments generally provide care for patients aged 65 years
and above or for patients with significant somatic comorbidity.
None of the available trials has assessed somatic comorbidity
systematically, let alone the impact of somatic comorbidity on
treatment feasibility and treatment effects.
Towards treatment possibilities in later life
Despite these limitations, consensus seems to emerge that in later
life, antidepressants may be more effective than CBT and that the
cognitive aspects of CBT are less effective. Behavioural techniques,
especially relaxation therapy, seem the most effective CBT
components in later life.6 Cognitive–behavioural therapy might
thus be less effective in older persons compared with their younger
counterparts. Up until now, direct comparisons between older
and younger patients with anxiety disorders were not available.
In this issue, Wetherell and colleagues have analysed the results
of the Coordinated Anxiety Learning and Management (CALM)
study by age.10 The CALM study examines the effectiveness of
collaborative care for generalised anxiety disorder, panic disorder,
social phobia or PTSD in 1004 patients within a randomised
controlled design. Wetherell et al’s paper is the first direct
comparison of treatment outcome between younger (age 18–59
years) and older patients (age 60–75 years) with anxiety disorders,
including a relatively large number of older patients (n=134/
1004, 13.3%). The results confirm the hypothesis that late-life
anxiety disorder is more treatment resistant compared with
anxiety disorder in younger patients. Limited by low patient
numbers, post-hoc analyses per anxiety disorder suggest that in
later life the best results can be achieved in patients with social
phobia or PTSD. The lower treatment effectiveness argues for
the development of age-specific strategies in later life. Some recent
developments are interesting. First, enhanced CBT may improve
treatment outcome.11 Enhanced CBT consists of regular CBTwith
the addition of learning and memory aids designed to increase
homework compliance, strengthen memory for therapeutic
techniques, and to facilitate the use of these techniques. Second,
third-wave CBT seems promising for older people, such as
acceptance and commitment therapy and mindfulness-based
stress reduction.12 Although third-wave CBT is quite heterogeneous
and includes a diversity of techniques, an important common
factor is the abandonment or cautious use of content-oriented
cognitive interventions typically part of second-generation
CBT. As cognitive interventions are assumed to be less effective
in later life, third-wave CBT may offer promising alternatives.
Third, if antidepressants are indeed the most efficacious strategy
in later-life, clinical trials should also focus on augmentation
strategies. Recently, a pilot study suggested that drug therapy
can be efficiently augmented with personalised modular CBT.13
Furthermore, as older people benefit most from relaxation
exercise,6 it is worthwhile to examine the effect when augmented
with pharmacotherapy.
It is not difficult to conclude that significant work has to be
done in this area. I hope the paper by Wetherell and colleagues,10
that confirms the lower treatment efficacy for late-life anxiety
disorder, will motivate the field to develop more age-specific
treatment strategies.
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